(HealthDay)—Teens and young adults who are seriously ill should have a chance to be involved in end-of-life decisions, and a new planning guide—developed especially for this age group—can help, researchers say.
Oct 8, 2012
0
0
A sugar-loving protein drives the growth of Kaposi sarcoma (KS) tumors, according to a study published on October 1st in The Journal of Experimental Medicine. Interfering with these sugary interactions inhibited growth of ...
Oct 1, 2012
0
0
A Florida State University researcher is on a mission to explore the gene-controlling effects of addictive drugs in pursuit of new HIV treatments.
Sep 21, 2012
0
0
Scientists at the Gladstone Institutes have gotten us one step closer to understanding and overcoming one of the least-understood mechanisms of HIV infection—by devising a method to precisely track the life cycle of individual ...
Sep 11, 2012
0
0
Less than half of community-based substance abuse treatment programs in the United States currently make HIV testing available on-site or through referral. A new study led by researchers at Weill Cornell Medical College shows ...
Sep 9, 2012
0
0
In South Africa, HIV-infected men who are receiving treatment with anti-HIV drugs (antiretroviral therapy) are almost a third more likely to die than HIV-positive women who are receiving similar treatment: however, these ...
Sep 4, 2012
0
0
(AP) —Brazil's anti-AIDS program will be expanded to include at least 35,000 more people, a Health Ministry official said Wednesday.
Aug 29, 2012
0
0
(Medical Xpress)—Can HIV be transformed into a biotechnological tool for improving human health? According to a CNRS team at the Architecture et Réactivité de l'ARN (RNA Architecture and Reactivity) laboratory, the answer ...
Aug 29, 2012
0
0
Community pharmacies with specially trained staff to provide HIV services can help HIV-infected individuals be more compliant with their essential antiviral drug regimens and hence improve patient outcomes. Users of HIV-specialized ...
Aug 14, 2012
0
0
Women comprise nearly half of the HIV-infected population worldwide, but these 15.5 million women tend to be under-represented in clinical trials of anti-HIV drug therapies. The U.S. Food and Drug Administration (FDA) has ...
Aug 9, 2012
0
0
